Common Contracts

EX-10.8 13 a2236234zex-10_8.htm EX-10.8

Asset Purchase Agreement • May 5th, 2020

• Contract Type
  Asset Purchase Agreement
• Filed
  May 5th, 2020

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended

Contract

Asset Purchase Agreement • July 18th, 2018 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Asset Purchase Agreement
• Filed
  July 18th, 2018
• Company
  Aridis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended

Contract

Asset Purchase Agreement • April 20th, 2018 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations

• Contract Type
  Asset Purchase Agreement
• Filed
  April 20th, 2018
• Company
  Aridis Pharmaceuticals, Inc.
• Industry
  Pharmaceutical preparations

Portions of this Exhibit, indicated by the mark “[***],” were omitted and have been filed separately with the Securities and Exchange Commission pursuant to the Registrant’s application requesting confidential treatment pursuant to Rule 406 of the Securities Act of 1933, as amended